Investor Login

Category: Investor News

Vaneltix enters joint development agreement with Hyloris Pharmaceuticals

On Thursday, December 16, Vaneltix entered into a Joint Development Agreement with Hyloris Pharmaceuticals NV, a Belgian pharmaceuticals company (“Hyloris”)…
Read More

Closing of shareholder offering

Vaneltix announces the results of the 2020 Stockholder Offering and Bridge Loan Conversion: The company raised additional proceeds of $900,000…
Read More
Vaneltix Pharma, Inc.
317 George St., Ste. 400,
New Brunswick, NJ 08901
United States

  • Tel:

    (732) 354-3217

  • Fax:

    (732) 354-3205

  • Email:

    Info@vaneltix.com
2021 © Vaneltix. All rights reserved.
Privacy Policy
Privacy Policy
This website is created by Blink.